Decibel Therapeutics, Inc(NASDAQ:DBTX) 
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-28
P
O 2.79
H 3.04
L 2.68
C 2.71
V 22,781
10EMA 2.71
20EMA 2.71
60EMA 2.71
120EMA 2.71
250EMA 2.71